SAM
KYMR icon

Simplify Asset Management’s Kymera Therapeutics KYMR Stock Holding History

Simplify Asset Management’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-30,515
Closed -$1.23M – 102
2024
Q4 		$1.23M Hold
30,515
– – 0.06% 62
2024
Q3 		$1.44M Hold
30,515
– – 0.07% 61
2024
Q2 		$911K Hold
30,515
– – 0.06% 75
2024
Q1 		$1.23M Hold
30,515
– – 0.07% 69
2023
Q4 		$777K Hold
30,515
– – 0.07% 77
2023
Q3 		$424K Buy
30,515
+19,983
+190% +$402K 0.05% 101
2023
Q2 		$242K Hold
10,532
– – 0.03% 106
2023
Q1 		$312K Buy
+10,532
New +$340K 0.04% 100

Other funds holding KYMR

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Simplify Asset Management's KYMR Position: Q1 2025 in Review

Simplify Asset Management sold out of Kymera Therapeutics (KYMR) in Q1 2025, closing a stake of 30,515 shares — an estimated $1.23M sold.

Simplify Asset Management first reported a position in KYMR in Q1 2023 and held it in 8 quarters. The position peaked at $1.44M in Q3 2024. 173 funds tracked by Wall St. Rank hold KYMR as of Q1 2025.

  • Simplify Asset Management reported no remaining Kymera Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Simplify Asset Management sold 30,515 Kymera Therapeutics shares in Q1 2025, an estimated $1.23M.
  • Simplify Asset Management first reported a position in Kymera Therapeutics in Q1 2023 and held it in 8 quarters.
  • Simplify Asset Management's Kymera Therapeutics position peaked at $1.44M in Q3 2024.
  • 173 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q1 2025.

Based on Simplify Asset Management's 13F filing for Q1 2025, filed 13 May 2025.